JNJ - Rallybio shares gain on investment from J&J for rare fetal condition treatment
2024-04-11 07:00:37 ET
Rallybio ( NASDAQ: RLYB ) shares surged in premarket trading on Thursday, on collaboration with Johnson & Johnson ( NYSE: JNJ ) to support the development of complementary therapeutic approaches aimed at reducing the risk of fetal and neonatal alloimmune thrombocytopenia....
Rallybio shares gain on investment from J&J for rare fetal condition treatment